| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $686.6M | $545.5M | $463.4M |
| YoY Revenue Growth % | +25.9% | +17.7% | — |
| Gross Profit | $268.8M | $215.6M | — |
| Gross Margin % | 39.1% | 39.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$45.5M | -$56.1M | -$73.6M |
| Operating Margin % | -6.6% | -10.3% | -15.9% |
| Net Income (GAAP) | -$61.7M | -$50.4M | -$67.5M |
| EBITDA (Normalized) | -$21.4M | -$41.7M | -$56.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.1M | -$15.4M | -$29.9M |
| Capital Expenditures (CapEx) | $30.2M | $18.1M | $20.9M |
| Free Cash Flow (FCF) | -$24.1M | -$33.5M | -$50.7M |
| FCF Margin % | -3.5% | -6.1% | -10.9% |
| Return on Invested Capital (ROIC %) | -7.9% | -9.7% | -3.0% |
| Cash & Short-Term Equivalents | $15.0M | $22.2M | — |
| Total Debt (Short + Long Term) | $192.1M | $164.0M | $743.8M |
| Total Stockholders' Equity | $275.6M | $314.5M | $1.53B |